Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases
- 1 February 1988
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 37 (2) , 133-135
- https://doi.org/10.1002/jso.2930370214
Abstract
The tumor markers carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), and carbohydrate antigen 19/9 (CA19/9) have been compared with regard to their sensitivity to liver diseases. All three markers have been found to be sensitive to liver diseases, but to a different degree: TPA rises the most; CEA the least. The sensitivities of TPA and CA19/9 are higher in a group of liver diseases than, for comparison, in a group of colorectal carcinomas.Keywords
This publication has 7 references indexed in Scilit:
- Reaction of the tumor markers cea and tpa to a surgical traumaJournal of Surgical Oncology, 1986
- Accurate prediction of experimental cancer chemosensitivity using the subrenal capsule xenograft assayJournal of Surgical Oncology, 1986
- Determination of Tissue Polypeptide Antigen (TPA) Levels in Different Cancer Types and ControlsOncology, 1985
- A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinomaWorld Journal of Surgery, 1984
- Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.Journal of Clinical Pathology, 1984